Skip to main content

Jessica Miller

Authored Items

Approval of First Liquid Biopsy to Detect EGFR Mutations in Lung Cancer Can Improve Patient Outcomes
By Jessica Miller
TOP - August 2016, Vol 9, No 3
Lung Cancer, FDA Approvals
The first liquid biopsy used to detect gene mutations that are associated with non–small-cell lung cancer (NSCLC) was approved by the US Food and Drug Administration (FDA). Read More ›